AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹48,492 Cr | ₹43,859 Cr | ₹39,213 Cr | ₹33,633 Cr | ₹33,401 Cr |
What is the latest Total Liabilities ratio of AUROBINDO PHARMA ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹48,492 Cr |
| Mar2024 | ₹43,859 Cr |
| Mar2023 | ₹39,213 Cr |
| Mar2022 | ₹33,633 Cr |
| Mar2021 | ₹33,401 Cr |
How is Total Liabilities of AUROBINDO PHARMA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹48,492 Cr | 10.56 | |
| Mar2024 | ₹43,859 Cr | 11.85 | |
| Mar2023 | ₹39,213 Cr | 16.59 | |
| Mar2022 | ₹33,633 Cr | 0.69 | |
| Mar2021 | ₹33,401 Cr | - | |
Compare Total Liabilities of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹70,546.9 Cr | 1.3% | 0.5% | -10.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹414,929.0 Cr | 0.7% | -4.2% | -8.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,644.0 Cr | 0% | -1% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹131,481.0 Cr | 2.4% | 4.5% | 14.5% | Stock Analytics | |
| CIPLA | ₹122,050.0 Cr | 1.1% | 0.2% | -1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,784.0 Cr | -1% | -2% | -9.7% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 1.3% |
0.5% |
-10.6% |
| SENSEX | 0.9% |
0.7% |
9.6% |
You may also like the below Video Courses